Detalhe da pesquisa
1.
Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in The Gambia: an observational cohort study.
Lancet Infect Dis
; 24(4): 417-426, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237616